IP Library Granted Patent US 11,246,959
Granted Patent B2
US 11,246,959 · App. 16/904,097 · Granted Feb 15, 2022

Biocompatible fiber textiles for implantation

Inventor: Jed K. Johnson (London, OH)
Assignee: NANOFIBER SOLUTIONS, LLC
A61L27/14A61L27/26A61L27/50D01D5/0076D06M23/08A61L2400/12A61L2430/22C08L75/04Y10T428/1362
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,246,959
App. No.
16/904,097
Granted
Feb 15, 2022
Kind
B2
Abstract

A biocompatible textile and methods for its use and fabrication are disclosed. The textile may be fabricated from electrospun fibers forming windings on a mandrel, in which the windings form openings having a mesh size between adjacent windings. The textile may also be fabricated by the addition of solvent-soluble particles incorporated into the textile while the windings are formed. Such particles may be removed by exposing the textile to a solvent, thereby dissolving them. Disclosed are also replacements for animal organs composed of material including at least one layer of an electrospun fiber textile having a mesh size. Such replacements for animal organs may include biocompatible textiles treated with a surface treatment process.

Claims (20)

1. A biocompatible textile comprising:

a network of a plurality of windings formed into a luminal structure, the plurality of windings comprising at least one polymeric electrospun fiber;

wherein the at least one polymeric electrospun fiber comprises a combination of polyethylene terephthalate and polyurethane in a weight percent ratio of polyethylene terephthalate to polyurethane of 10% to 75%; and

wherein the network has a mesh size of 1 opening per mm to 20 openings per mm.

2. The biocompatible textile of claim 1 , wherein the at least one polymeric electrospun fiber comprises an at least one surface-treated polymeric electrospun fiber.

3. The biocompatible textile of claim 1 , wherein the plurality of windings forms a plurality of circumferential layers.

4. The biocompatible textile of claim 3 , further comprising at least one curved polymer support in mechanical communication with at least one of the plurality of circumferential layers.

5. The biocompatible textile of claim 4 , wherein the at least one curved polymer support is a U-shaped support.

6. The biocompatible textile of claim 1 , shaped into a replica of an organ selected from the group consisting of a trachea, a trachea and at least a portion of at least one bronchus, a trachea and at least a portion of a larynx, a larynx, an esophagus, a large intestine, a small intestine, an upper bowel, a lower bowel, a vascular structure, and portions thereof.

7. A method for fabricating a biocompatible textile comprising:

electrospinning a biocompatible polymer into an electrospun fiber, wherein the electrospun fiber comprises a combination of polyethylene terephthalate and polyurethane in a weight percent ratio of polyethylene terephthalate to polyurethane of 10% to 75%;

contacting the electrospun fiber with a particulate material having a solubility in a solvent;

contacting the electrospun fiber with a mandrel, thereby forming a polymer network thereon comprising a plurality of windings formed into a luminal structure, the plurality of windings comprising a plurality of electrospun fiber threads having a plurality of spaces between adjacent electrospun fiber threads;

removing the polymer network from the mandrel; and

dissolving the particulate material with the solvent that may not otherwise dissolve the electrospun fibers, thereby forming a biocompatible textile having a mesh size of 1 opening per mm to 20 openings per mm.

8. The method of claim 7 , wherein the mandrel has a shape based on a biological organ of a patient.

9. The method of claim 7 , wherein the mandrel has a shape determined by a computer model.

10. The method of claim 7 , wherein the mandrel is a collapsible mandrel.

11. The method of claim 7 , wherein the particulate material is a water soluble salt, a water soluble sugar, a water soluble hydrogel, or any combination thereof.

12. The method of claim 7 , further comprising treating the polymer network with a treatment selected from the group consisting of washing in a solvent, drying with a gas stream, sterilizing, sintering, and treating with a plasma discharge.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2022
From: NANOFIBER SOLUTIONS, LLC
To: NFS IP HOLDINGS, LLC
Reel/Frame 061882/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2020
From: JOHNSON, JED K.
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 053244/0768 →
Continuity (3)
Continuation 14216976 · Mar 17, 2014
Provisional Application 61798265 · Mar 15, 2013
Related Publication 20210138108A1 · May 13, 2021